doi: 10.1038/s41598-022-17338-1 49
Both the Kidney Disease Improving Global Outcomes guidelines and American Diabetes Association Standards of Care recommend GLP1-RA as the preferred glucose lowering class for people with T2D and moderate to advanced CKD or ESRD because of their demonstrated cardiovascular benefits in people with T2D at high risk of cardiovascular disease, which includes CKD 13,14
They also help you feel full for a longer time, so you eat less
For patients, coaches, and health professionals, the real takeaway is straightforward: Work with licensed medical providers
Mallick B, Shrama DJ, Siddappa P, et al
Aplicar conforme o protocolo esttico adotado e a orientao do profissional responsvel